Unmet needs in the Treatment of Advanced Hepatocellular Carcinoma

According to the Barcelona Clinic Liver Cancer staging system (BCLC), the current standard treatment for patients with advanced hepatocellular carcinoma is sorafenib. However, the survival gain is still unsatisfactory. Therefore, novel systemic molecular targeted agent and their combinations or combining other forms of therapies are needed.